Postmenopausal Ovaries May Have an Immune Role

Menopause is commonly defined as the point when ovulation and menstrual periods permanently end. That definition is accurate, but it may not capture the full biological story.

Emerging research suggests that postmenopausal ovaries may retain or develop another function involving the immune system and the biology of aging. Media reports have described this possibility as a “second job” for the ovaries after reproduction ends. ScienceAlert

The idea does not mean that ovaries resume ovulation, restore fertility, or return to their premenopausal state. It suggests that ovarian tissue may remain biologically relevant after reproductive activity declines. A separate report from Science | AAAS describes a possible transformation of postmenopausal ovaries into tissues with immune functions.

However, the available evidence is limited. The supplied reports do not identify the study design, sample size, biological mechanism, or whether the research involved humans, animals, laboratory tissue, or a scientific review. The proposed immune role should therefore be treated as an emerging hypothesis, not an established medical fact.

What Happens to the Ovaries During Menopause?

Menopause marks the permanent end of menstrual periods after ovarian follicular activity declines. The ovaries no longer release eggs regularly, and reproductive hormone production changes substantially.

Estrogen and progesterone levels generally decrease as ovarian activity declines. The transition is gradual for many people. Perimenopause may last several years and can involve irregular periods, fluctuating hormone levels, hot flashes, sleep disruption, mood changes, and other symptoms.

The timing and severity of symptoms vary. Menopause may occur naturally with age or result from medical treatment, including surgery or therapies that affect ovarian function.

The Ovaries Do Not Simply Disappear

The ovaries remain anatomically present after natural menopause unless they have been surgically removed. Their reproductive activity changes, but reproductive inactivity does not mean complete biological inactivity.

This distinction is central to the emerging research. The possibility that postmenopausal ovarian tissue participates in immune processes challenges the assumption that ovaries become biologically irrelevant once fertility ends.

That possibility does not mean that every postmenopausal ovary behaves identically. Age, genetics, health conditions, medications, hormone therapy, previous pregnancies, and the cause of menopause may all affect ovarian tissue.

Hormonal Changes Affect the Whole Body

The decline in ovarian hormones affects multiple systems, including bone health, cardiovascular risk, metabolism, the brain and nervous system, and reproductive tissues.

These effects explain why researchers are examining postmenopausal ovaries beyond their role in fertility. An organ can have several biological functions, and their importance can change across the lifespan.

The Possible “Second Job” of Postmenopausal Ovaries

Reports from ScienceAlert, Science | AAAS, and other outlets describe research into whether ovaries may develop or support immune functions after menopause.

The broad idea is that ovarian tissue could be repurposed after reproductive activity declines. Instead of serving primarily as a source of eggs and reproductive hormones, it might communicate with the immune system or participate in processes associated with aging.

The available summaries do not identify the exact immune cells, signaling pathways, proteins, or tissue changes involved. It is therefore not possible to say precisely what the proposed function is or how large its effect might be.

What “Immune Function” Could Mean

Immune function is a broad term. An organ may influence immunity by:

• Producing immune-related signaling molecules
• Hosting immune cells
• Regulating inflammation
• Communicating with immune organs and tissues
• Changing its cellular composition with age
• Responding to hormones, infections, or damaged tissue

The reports do not establish which of these possibilities applies to postmenopausal ovaries. Further research must identify the cells involved and determine whether their activity is consistent across individuals.

The phrase “second job” is an accessible description, not a formal medical diagnosis. It summarizes the possibility that ovarian tissue may have a role beyond reproduction.

A Shift From Reproduction to Maintenance?

Biology often changes across the lifespan. An organ’s function during development or reproduction may differ from its function later in life. Reproductive organs can continue interacting with the immune, endocrine, nervous, and metabolic systems after fertility ends.

A possible immune role would represent tissue adaptation, not a return to reproductive activity. The ovaries would not be restarting ovulation or producing eggs. They could instead participate in maintenance, signaling, or inflammatory regulation.

Whether this reflects active adaptation, a passive consequence of aging, or a response to changing hormone levels remains unknown.

How Could Ovaries Influence Immune Aging?

Immune aging, or immunosenescence, describes gradual changes in immune-system performance over time. Aging can affect the body’s ability to respond to unfamiliar infections, generate strong vaccine responses, regulate inflammation, and produce or activate immune cells.

Immune aging does not occur at the same rate in everyone. Genetics, chronic illness, infections, medications, nutrition, physical activity, stress, and environmental exposures can all influence immune health.

The central research question is whether postmenopausal ovarian tissue helps regulate immune changes later in life. This is biologically plausible because reproductive hormones and immune activity interact. Estrogen, progesterone, and other ovarian signals can influence inflammation and immune-cell behavior. However, plausibility is not proof.

The available reports do not show that ovaries prevent immune aging, restore immune strength, or protect against a particular disease. They also do not establish that a postmenopausal immune role is beneficial. The change could support healthy regulation, contribute to inflammation, or have little clinical effect.

A cause-and-effect relationship would require studies comparing ovarian tissue, immune markers, health outcomes, age, hormone exposure, and other relevant factors.

What the Reports Say

A ScienceAlert report presents the broad finding that ovaries may develop an additional biological role after menopause. The supplied summary offers no detailed information about the underlying study.

A Science | AAAS summary gives the immune system a more prominent role, describing the possibility that ovaries transform after menopause into tissues with immune functions. The summary does not provide enough information to identify the mechanism, study population, or medical significance.

An MDLinx report dated July 8, 2026, describes a possible role for postmenopausal ovaries in immune aging. That date requires editorial verification before publication. The supplied material does not include the original study or establish whether the findings came from human participants, animal models, laboratory tissue, or a review.

Reports from the Times of India and the New York Post describe a possible ovarian “second job” or unexpected postmenopausal activity. These articles demonstrate public interest, not independent confirmation. Multiple media reports may repeat the same underlying claim.

What Researchers Still Need to Establish

Researchers must determine which ovarian cells change after menopause, which immune signals they produce, and whether the tissue communicates directly with immune organs.

They must also establish whether the change occurs gradually or at a defined stage of menopause. Mechanistic evidence can help distinguish an active biological function from a nonspecific sign of aging or tissue damage.

The study population or model must be verified. Findings from cells or animals may reveal important biological possibilities, but they do not automatically translate to human health. Verification should include the original paper, study setting, participant characteristics, tissue source, methods, controls, and stated limitations.

Researchers also need to determine whether the function is helpful, harmful, or neutral. Immune activity is not automatically beneficial. Strong or poorly regulated immune signaling can contribute to inflammation, while insufficient activity may weaken defense against infection.

Bilateral oophorectomy, or surgical removal of both ovaries, may provide an important comparison for future research. Surgical menopause can have biological effects that differ from natural menopause. However, ovarian removal should not be described as a cause of immune problems without verified evidence. Comparisons are complicated by age, hormone therapy, cancer risk, underlying illness, genetic factors, and the reason for surgery.

What This Does Not Mean

An immune-related function would not mean that postmenopausal ovaries resume ovulation, restore menstrual cycles, release eggs, or restore the ability to become pregnant.

The finding does not establish a new treatment. No supplement, hormone, medication, or surgery should be promoted on the basis of this research alone. Preliminary biological findings require replication, clinical studies, and safety evaluation before they can change medical care.

Established menopause symptoms, including hot flashes, sleep disruption, vaginal dryness, mood changes, and bone loss, should be discussed with a qualified clinician when they affect health or quality of life. The possible ovarian immune role does not replace established menopause care or prove that symptoms are caused by an immune change.

Why This Research Matters

Menopause is often described primarily as the end of reproduction. That description is important but may be incomplete if postmenopausal ovarian tissue continues interacting with other body systems.

Studying postmenopausal physiology directly could improve understanding of inflammation, immune aging, metabolic health, disease risk, and sex-related differences in immune responses. It may also clarify the long-term effects of ovarian removal and the differences between natural and surgical menopause.

Careful reporting remains essential. Established facts about menopause should be distinguished from emerging hypotheses about postmenopausal ovarian function.

Conclusion

Postmenopausal ovaries may have an immune-related role connected to aging. This possibility challenges the idea that ovaries become completely inactive after menopause.

The evidence described in the supplied reports remains limited. The mechanism is unclear, study details are unavailable, and clinical significance has not been established. The reports do not show that ovaries prevent immune aging, restore immunity, or provide a basis for new treatment.

The next research priority is to determine how ovarian tissue changes after menopause, identify the cells and signals involved, and establish whether those changes influence immune health in humans.

Frequently Asked Questions

Do ovaries still function after menopause?

Ovaries generally stop ovulating and produce much lower levels of reproductive hormones after menopause. Emerging research suggests that they may retain or develop other biological functions, including a possible relationship with immune activity.

What is the possible second role of the ovaries after menopause?

Current reports describe a possible role involving immune function and immune aging. The exact activity, mechanism, and health effects remain under investigation.

Do postmenopausal ovaries produce estrogen?

Estrogen production decreases substantially after menopause but does not necessarily fall to zero. Other tissues, including body fat and the adrenal glands, also contribute to postmenopausal estrogen production.

Could postmenopausal ovaries affect the immune system?

Researchers are investigating this possibility. The available summaries do not prove that ovaries control immunity, prevent immune aging, or protect against specific diseases.

Does this discovery change menopause treatment?

No. The available evidence does not support changing menopause treatment. Symptoms, hormone therapy, bone health, cardiovascular risk, and preventive care should be discussed with a qualified clinician.

Should people have their ovaries removed after menopause?

This research does not support preventive ovary removal. Oophorectomy is an individual medical decision involving risks, benefits, age, genetic factors, symptoms, cancer risk, and medical history.